Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.
Coeptis Therapeutics has raised $4.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2025.
Coeptis Therapeutics's investors include CJC.
Coeptis Therapeutics is headquartered in Wexford, United States.
Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.
Coeptis Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Coeptis Therapeutics — Funding & Investors." VCBacked, August 6, 2025, https://www.vcbacked.co/company/coeptis-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Coeptis Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/coeptis-therapeutics
{{cite web |title=Coeptis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/coeptis-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated